Loading ...

Stock Quote cx5n

cx5n Stock Price Today

cx5n Price History

cx5n Stock Price History

cx5n History

Last Price cx5n

Close Price cx5n

Day Change cx5n

After Hours Quote cx5n

Open Price cx5n

Day Range cx5n

Year Range cx5n

Projected Yield cx5n

Market Cap cx5n

Stock Volume cx5n

Average Volume cx5n

Forward Price cx5n

PE for cx5n

PB for cx5n

PS for cx5n

PCF for cx5n

price earnings ratio cx5n

price to book ratio cx5n

price to sales ratio cx5n

price to cash flow ratio cx5n

Stock Quote CytRx Corp

CytRx Corp Stock Price today

CytRx Corp Price history

CytRx Corp Stock Price history

CytRx Corp history

Last Price CytRx Corp

Close Price CytRx Corp

Day Change CytRx Corp

After Hours Quote for CytRx Corp

Open Price CytRx Corp

Day Range CytRx Corp

Year Range CytRx Corp

Projected Yield CytRx Corp

Market Cap CytRx Corp

Stock Volume CytRx Corp

Average Volume CytRx Corp

Forward Price CytRx Corp

pe CytRx Corp

pb CytRx Corp

ps CytRx Corp

pcf CytRx Corp

price earnings ratio CytRx Corp

price to book ratio CytRx Corp

price to sales ratio CytRx Corp

price to cash flow ratio CytRx Corp

What Does This Company Do?
CytRx Corp is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes three clinical-stage drug candidates in various stages of development: Aldoxorubicin, Tamibarotene, and Bafetinib.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Distressed
Employees
17
Stock Style
Small Growth

Key Stats  CX5N More...

Key Stats CX5N

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  cx5n - CytRx Corp More...

Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors of the May 13, 2014 Deadline to File for Lead Plaintiff in the Securities Fraud Class Action Against CytRx Corporation -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CytRx Corporation and Certain Officers -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in CytRx Corporation of Class Action Lawsuit and Upcoming Deadline -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR
Gainey McKenna & Egleston Reminds Investors That a Class Action Lawsuit Has Been Filed Against CytRx Corporation -- CYTR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR (2014/4/11)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  cx5n - CytRx Corp More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports cx5n - CytRx CorpMore...

Click above to view more mutual fund data and stats for cx5n - CytRx Corp.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   CX5N More ...

Ownership CX5N

Vanguard Total Stock Mkt Idx
Franklin Biotechnology Discovery A
Vanguard Extended Market Idx Inv
iShares Russell 2000 Value
Fidelity Spartan® Extended Mkt Index Inv

Wall St. Recommendations  cx5n - CytRx Corp More...

Wall Street Analyst Recommendation CX5N

Stock Price Quote: cx5n CytRx Corp - XFRA - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: cytr - CytRx Corp  |  Next: cyca - Cytta Corporation